Latest Breaking News On - United kingdom medicines - Page 7 : comparemela.com

Mundipharma acquires all assets and rights related to REZZAYO® (rezafungin), reinforcing continued commitment to management of infectious diseases and specialty care therapeutic area

Mundipharma acquires all assets and rights related to REZZAYO® (rezafungin), reinforcing continued commitment to management of infectious diseases and specialty care therapeutic area
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesMarc princenAsia pacificAntimicrob chemotherDrug administrationEuropean commissionHealthcare products regulatory agencyEuropean medicines agencyNapp pharmaceutical groupVp communications corporate affairsMinistry of healthChief executive officerUnited kingdom medicinesOrphan drug designationNapp pharmaceutical group limited

Cidara Therapeutics (CDTX) Announces Divestiture of Rezafungin to Mundipharma

Cidara Therapeutics (CDTX) Announces Divestiture of Rezafungin to Mundipharma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomJeffrey steinRegulatory agencyNapp pharmaceutical groupCidara therapeutics incCidara therapeuticsMelinta therapeuticsUnited kingdom medicinesNapp pharmaceutical group limited

Mundipharma acquires all assets and rights related to REZZAYO (rezafungin), reinforcing continued commitment to management of infectious diseases and specialty care therapeutic area

Mundipharma acquires all assets and rights related to REZZAYO (rezafungin), reinforcing continued commitment to management of infectious diseases and specialty care therapeutic area
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesAsia pacificAntimicrob chemotherDennis riedlMarc princenHealthcare products regulatory agencyEuropean medicines agencyEuropean commissionVp communications corporate affairsNapp pharmaceutical groupDrug administrationMinistry of healthChief executive officerUnited kingdom medicinesOrphan drug designation

Stocks that will see action today (April 22) - The Hindu BusinessLine

Stocks that will see action today (April 22) - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Madhya pradeshUnited statesUnited kingdomSouth africaGreat britainZydus lifesciencesAditya birlaSterlite technologieDrug administrationRegulatory agency for nulibryNeo energySterling wilson renewable energyLupin ltdHdfc bankSentynl therapeutics incKids services

Unlocking innovative hydrogel treatments

Unlocking innovative hydrogel treatments
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

United kingdomGarry laverty sreekanth pentlavalliInstitut laue langevinSreekanth pentlavalliJ clin pharmacolGarry lavertySchool of pharmacy queen university belfastQueen university belfastScience lecturer at bradford universityResearch fellow at school of pharmacyTechnology facilities councilEngineering physical sciences research councilDrug administrationNature communicationsUniversity belfastMuon source